6733 博晟生醫歷年利潤比率
| 年度/季別 | 毛利率 | 營業利益率 | 稅前淨利率 | 稅後淨利率 |
|---|
| 2025Q2 | 72.14% | -55.57% | -53.28% | -49.30% |
| 2025Q1 | 76.82% | -86.35% | -81.05% | -76.62% |
| 2024Q4 | 75.45% | -46.71% | -65.18% | -61.21% |
| 2024Q3 | 75.36% | -84.71% | -83.69% | -78.95% |
| 2024Q2 | 79.70% | -114.27% | -109.50% | -103.87% |
| 2024Q1 | 82.41% | -52.23% | -49.05% | -43.14% |
| 2023Q4 | 85.44% | -101.85% | -100.48% | -95.41% |
| 2023Q3 | 72.25% | -246.18% | -227.36% | -217.40% |
| 2023Q2 | 85.01% | -67.83% | -63.04% | -57.58% |
| 2023Q1 | 73.00% | -539.14% | -530.17% | -510.76% |
| 2022Q4 | 63.98% | -561.40% | -542.96% | -523.87% |
| 2022Q3 | 84.13% | -641.96% | -634.09% | -612.15% |
| 2022Q2 | 87.79% | -709.42% | -690.73% | -655.23% |
| 2022Q1 | 50.38% | -1088.87% | -1060.06% | -1017.83% |
| 2021Q4 | 56.16% | -1010.57% | -414.54% | -414.54% |
| 2021Q3 | -44.59% | -1776.57% | -1939.59% | -1939.59% |
| 2021Q2 | 51.19% | -2648.81% | -2834.37% | -2834.37% |
| 2021Q1 | 52.39% | -4046.14% | -4304.60% | -4304.60% |
| 2020Q4 | 54.86% | -9075.24% | -9785.27% | -9785.27% |
| 2020Q3 | 83.02% | -6872.67% | -7515.45% | -7515.45% |